Company / Revenue
Arcadia Biosciences, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$5.0M
FY2025
5-year range
$4.5M / $8.0M
FY2021-FY2025
Trend
+13.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $1M in FY2020 to $8M in FY2021.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of +34.0%.
Declined from $7M to $5M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -9.4%
- 5-Year CAGR
- +34.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +34.0%, indicating consistent growth.
- In FY2025, revenue increased 13.3% year-over-year.
- Peak revenue was recorded in FY2021.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0M | +13.3% |
| FY2024 | $4.5M | -40.0% |
| FY2023 | $7.4M | +9.4% |
| FY2022 | $6.8M | -15.6% |
| FY2021 | $8.0M | +587.3% |
| FY2020 | $1.2M | -20.2% |
| FY2019 | $1.5M | -63.6% |
| FY2018 | $4.0M | +26.3% |
| FY2017 | $3.2M | -41.1% |
| FY2016 | $5.4M | -22.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026